Tata Health International Holdings Limited has announced a continued suspension of trading of its shares on the Hong Kong Stock Exchange. The trading halt, initiated at the Company's request, has been in effect since April 2, 2024, as the company works to address issues outlined by the Stock Exchange. The suspension will remain until Tata Health fully complies with the Listing Rules to the satisfaction of the Stock Exchange of Hong Kong Limited. Shareholders and potential investors are advised to exercise caution.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tata Health International Holdings Limited published the original content used to generate this news brief on September 15, 2025, and is solely responsible for the information contained therein.